Glutathione synthetase (GSH-S) is one of the two known hereditary causes of glutathione deficiency. We describe a family whose two children have hemolytic anemia. The children's erythrocytes lack GSH and are severely deficient in GSH-S activity. No neurologic findings or 5-oxoprolinuria were present. A concurrent deficiency of glutathione-S-transferase (GST) was also detected in the erythrocytes. Residual glutathione could be detected in the erythrocytes using a sensitive cycling assay. The deficiency was found to be most severe in reticulocyte-depleted preparations. The GSH-S activity of the erythrocytes of the parents was one-half normal, while the glutathione S-transferase activity was normal. We conclude that the primary defect is one of GSH-S. Glutathione stabilizes GST in vitro, and it is assumed that the deficiency of GST in the erythrocytes of the patients is due to the instability of this enzyme in the absence of adequate intracellular GSH levels.
Introduction
A variety of methods have been devised to deplete cells of glutathione (1-3), but none is as informative as hereditary defects in synthesis of this tripeptide. Reduced glutathione (GSH) is synthesized in two steps. First, a peptide bond is formed between the y-carboxyl group of glutamate and the amino group of cysteine to form the dipeptide, y-glutamyl-cysteine. This reaction is catalyzed by the enzyme y-glutamyl-cysteine synthetase (GC-S). Then, the formation of a peptide bond between 'y-glutamyl cysteine and glycine is catalyzed by a second enzyme, glutathione synthetase (GSH-S). ATP serves as a source of energy for both reactions. They may be summarized as follows: glutamate + cysteine + ATP y-glutamyl-cysteine + ADP y-glutamyl-cysteine + glycine + ATP GSH + ADP Inherited deficiencies of each of these enzymes have been reported. Both are very rare and result in GSH deficiency. Glutathione deficiency has been associated with nonspherocytic hemolytic anemia and, in some instances, with other disturbances, including neurological disorders and metabolic acidosis.
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We have now had the opportunity to study two sibs with hemolytic anemia associated with a severe deficiency of erythrocyte GSH. The erythrocytes of these children were found to be deficient both in GSH-S and in glutathione-S-transferase (GST).' We provide evidence that the latter enzyme deficiency is secondary to the decreased levels of GSH in the erythrocyte, and that the primary defect is one of GSH-S activity.
Clinical history. Lazardo V. is a 13-yr-old boy born in Cuba 
Methods
Blood samples for enzyme assays were drawn into EDTA anticoagulant, -1 mg/ml blood, and shipped on ice by air to La Jolla for assay. All measurements were carried out within 4 d of the time the blood was drawn. Blood for the determination of metabolic intermediates was deproteinized with perchloric acid immediately upon drawing and neutralized (4) before shipment.
Enzyme assays were carried out as previously described (4). GSH-S activity was measured by our modification (5) ofthe method ofMinnich et al. (6) . GC-S activity was measured by estimating, by means of the pyruvate kinase reaction, the formation of ADP in a system containing hemolysate, ATP, cysteine, and glutamate. Representing a modification of the system described by Foure-Seelig and Meister (7) , the complete assay system contained 100 Mmol Tris-HCI (pH 8.0), 0.5 Mmol EDTA, 100 umol KCI, 20 umol MgCl2, 2 Mmol ATP, 0.2 jtmol NADH, 2.5 umol phosphoenolpyruvate, 10 jumol each cysteine and glutamic acid, 0.5 U each of pyruvate kinase and lactate dehydrogenase, and 50 M1 of a 1:10 stroma-free hemolysate in a total volume of 1 ml.
GSH estimations were performed using 5,5'-dithiobis(2-nitrobenzoic acid) (DTNB) (8) . In some instances the concentration oftotal glutathione 1. Abbreviations used in this paper: DTNB, 5,5'-dithiobis(2-nitrobenzoic acid); GC-S, 'y-glutamyl-cysteine synthetase; GSH, glutathione; GSH-S, glutathione synthetase; GST, glutathione-S-transferase; Hb, hemoglobin.
(oxidized + reduced) was determined by enzymatic cycling using our modification (8a) ofthe methods ofOwens and Belcher (9) and ofTietze (10) . Levels of metabolic intermediates were estimated fluorometrically and spectrophotometrically as previously described (4) .
Density separation of erythrocytes into light (reticulocyte-enriched) and dense (reticulocyte-poor) fractions was achieved using Percoll-Hypaque (11) .
Urinary 5-oxoproline was determined by measuring the glutamic acid concentration before and after acid hydrolysis of 5-oxoproline to glutamic acid. Urine samples were passed through a UM2 filter (Amicon Corp., Scientific Systems Div., Danvers, MA). After acidification with acetic acid to pH of 3.0 they were applied to a I X 6 cm Dowex 50 (hydrogen cycle) column (Bio-Rad Laboratories, Richmond, CA) that had been equilibrated with 1% acetic acid. The sample was washed through the column with 6 ml of 1% acetic acid and brought to a final volume of 10 
Results
The activities of erythrocyte enzymes of the patients and their parents are presented in Table I . The activities of GSH-S and of GST were markedly diminished, but the activity ofGC-S was normal. Very significantly, the activity ofGSH-S was about onehalf normal in both parents, but the activity ofGST was normal in the parents. As expected in children with an elevated reticulocyte count, the levels of some of the age-related enzymes were increased in the patients. Levels of metabolic intermediates are shown in Table II . It is apparent that both children had a profound deficiency of erythrocyte GSH. The amount of GSH in the erythrocytes was sufficiently low so as to be at the limit ofdetection by the DTNB method. For this reason the level of total glutathione was also estimated by enzymatic cycling, a technique that is several orders of magnitude more sensitive than the DTNB method. The application of this technique confirmed that glutathione was, indeed, present in the erythrocytes of the deficient patients.
Estimation of the levels of glutathione in reticulocyte-enriched and reticulocyte-depleted fractions of erythrocytes indicated that most of the residual glutathione was in the younger cells, and that these cells had an increased amount of residual GSH-S and GST activity (Table III) .
Leukocyte glutathione levels were also measured in the patients, their mother, and a concurrent normal control. Because of the small amount of blood available for study, only a mixed leukocyte fraction isolated by discontinuous density gradients of Ficoll-Hypaque (12) could be assayed. The amount of glutathione expressed as micromoles per gram protein found by enzymatic cycling was 11.8 and 9.5 in the two patients, 10.7 in the mother, and 10.0 in the concurrent control. The urinary 5-oxoproline level of Lazardo V. was 424 uM. A control sample contained 541 gM 5-oxoproline. Discussion GSH-S deficiency presents as two quite distinct clinical syndromes. The more severe of these is characterized by 5-oxoprolinuria, metabolic acidosis, and a neuromuscular disorder. Interestingly, although this syndrome was first reported in 1970 (13) it was not until four years later that the lack of glutathione in erythrocytes (14) and the basic enzymatic defect (15) (22, 23) . The present cases appear to be only the fourth family with GSH-S deficiency causing hemolytic anemia without neurologic disease. The urinary 5-oxoproline level in one other such patient has been measured (24) and, as in our case, was found to be normal. This finding implies that the erythrocyte, the only tissue presumably involved in this type of GSH-S deficiency, does not represent an important source of 5-oxoproline. (25) and this suggestion was verified in one previously studied case (24) . The leukocytes of our patient had normal enzyme activity. It is interesting to speculate how such differences in tissue distribution ofenzyme deficiencies may come about. Tissue-specific isozymes can be one explanation. Another is the susceptibility of mutant enzymes to proteases that are present only in the affected tissue (26) . Thus, a mutation involving GSH-S which rendered it susceptible to destruction by erythrocyte proteases, but not by proteases in other tissues, would be expressed only in the erythrocyte.
Erythrocyte glutathione deficiency may also rarely result from y-glutamyl synthetase deficiency. We are aware of only a single reported case (27) with this defect. A feature of glutathione deficiency that has not been described before is the marked decrease in the activity oferythrocyte GST. In developing an assay for this enzyme (28), we discovered that it was very rapidly denatured by the addition of one of its substrates, 1-chloro-2,4-dinitrobenzene. If GSH was added to the assay mixture before the addition of l-chloro-2,4-dinitrobenzene, the enzyme was protected against destruction. It is reasonable to suppose that the xenobiotics that GST normally functions to conjugate to glutathione in vivo might have the same capacity to destroy the enzyme in the absence of GSH. Indeed, the younger erythrocytes of the patient, which contained some residual GSH, also had higher GST levels. It seems unlikely that GST deficiency represented a primary lesion in these patients. The activity of the enzyme in the parents was normal, and it is difficult to see how a deficiency of this glutathioneconjugating enzyme would result in a deficiency of glutathione.
